MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Rating by Esther Rajavelu at Oppenheimer Holdings Inc. … Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $10.00 for Kala Pharmaceuticals in the next year. Kala Pharmaceuticals' physical mailing address is 490 ARSENAL WAY SUITE 120, WATERTOWN MA, 02472. Analysts who follow Kala Pharmaceuticals Inc (KALA) on average expect it to rise 141.12% over the next twelve months. See Tesla, Inc. (TSLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The average 1 Kala Pharmaceuticals, Inc. (NASDAQ:KALA) has been assigned an average recommendation of "Buy" from the eight research firms that are covering the stock, MarketBeat reports. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and six have given a buy recommendation to the company. See today’s analyst top recommended stocks >> Kala Pharmaceuticals, Inc. (KALA) 6.81 0.00 (0.00%) Analyst Ratings . Learn everything you need to know about successful options trading with this three-part video course. Historical Ratings. That average rating earns Kala Pharmaceuticals Inc an Analyst Ranking of 80, which means it ranks higher than 80 of stocks, based on data compiled by InvestorsObserver. 3.4 Analyst's Opinion. Analyst Information for Kala Pharmaceuticals Inc. $ 12.31 0.06 (+0.49%) Volume: 894.98k: 4:00 PM EDT May 29, 2020 After Hours: $ 12.28 -0.03 (-0.24%) Volume: 96.82k 5:35 PM EDT May 29, 2020 Consensus Rating Average: Consensus Rating for KALA is STRONG BUY: Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. View the latest price targets for KALA. Opinions of the stock are interesting as 6 analysts out of 7 who provided ratings for Kala Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.” According to TipRanks.com, Brisebois is a 4-star analyst with an average return of 12.3% and a 47.8% success rate. Start Your Risk-Free Trial Subscription Here, Alphabet The Best FAANG Stock to Buy in 2021, All Analysts Agree that these 3 Stocks are a Buy, RealNetworks (NASDAQ: RNWK) Stock a Legacy Reemergence Play, Regeneron (NASDAQ:REGN) Lands a Big Quarter, An Investment In Hershey’s Stock Looks Sweeter Than Ever. That average rating earns the stock an Analyst Ranking of 70, whic See Kala Pharmaceuticals, Inc. (KALA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Sign-up to receive the latest news and ratings for KALA and its competitors with Analyst for Wed, Dec 16th, 2020. The Scale of Ratings . No. Please log in to your account or sign up in order to add this asset to your watchlist. Analyst Ratings for Kala Pharmaceuticals (KALA) KALA Rating Summary. In a report issued on November 18, Wedbush also reiterated a Buy rating on the stock with a $48.00 price target. Several hedge funds and other institutional investors have recently added to or reduced their stakes in KALA. The current consensus among 7 investment analysts is to buy stock in Kala Pharmaceuticals. In a report issued on June 12, Liana Moussatos from Wedbush maintained a Buy rating on Kala Pharmaceuticals (KALA – Research Report), with a price target of $39.00.The company’s shares closed last Friday at $12.34. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. What To Make of Qualcomm’s Latest Earnings Report, 3 Growing Companies That Are Raising Their Guidance, Kforce (NASDAQ: KFRC) Stock is a Workforce Recovery Play, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, Receive Analysts' Upgrades and Downgrades Daily. Too Late to Buy Activision Blizzard Stock? Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. Northland Securities Keeps a Buy Rating on Kala Pharmaceuticals (KALA) In a report … Other equities analysts also recently issued reports about the stock. sell any security. The company's lead product candidate is KPI-121 0.25% which has completed two Phase III clinical trials for the treatment of temporary relief of the signs and symptoms of dry eye disease; INVELTYS which has completed two Phase III clinical trials for the treatment of inflammation and pain following ocular surgery; and KPI-285, a MPP receptor tyrosine kinase inhibitor program, which is in preclinical studies for the treatment of retinal diseases. Buys – 7; Neutrals – 1; Sells – 0; KALA Price Target Summary. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. All rights reserved. Wedbush analyst Liana Moussatos reiterated a Buy rating on Kala Pharmaceuticals (KALA – Research Report) yesterday and set a price target of $49.00. Equities analysts expect that Kala Pharmaceuticals, Inc. will post -1.88 EPS for the current fiscal year. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Get daily stock ideas top-performing Wall Street analysts. Date Rating Action Authority Current Price Target Price; 2020-11-30: … Analysts who follow Kala Pharmaceuticals Inc on average expect it to gain 306.74% over the next twelve months.Those same analysts give the stock an average rating of Strong Buy. A "buy" rating indicates that analysts believe KALA will outperform the market and that investors should add to their positions of Kala Pharmaceuticals. 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. The company has a consensus rating of "Buy" and a consensus price target of $19.31. Do Not Sell My Information. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Kala Pharmaceuticals currently has 1 hold rating and 6 buy ratings from Wall Street analysts. Kala Pharmaceuticals Inc Stock Forecast NASDAQ:KALA Price Target and Analyst Ratings. Kala Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. changes. Based on 7 analysts offering recommendations. Moussatos covers the Healthcare sector, focusing on stocks … Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. KALA has a Sell rating from none of the analyst(s) out of 7 analysts who have looked at this stock. This Buy consensus rating has held steady for over two years. InvestorsObserver is giving Kala Pharmaceuticals Inc (KALA) an Analyst Rating Rank of 71, meaning KALA is ranked higher by analysts than 71% of stocks. To see all Based on analysts offering 12 month price targets for KALA in the last 3 months. Kala Pharmaceuticals has received a consensus rating of Buy. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. According to TipRanks.com, Brisebois is a 4-star analyst with an average return of 11.0% and a 47.7% success rate. Last 30 Days. See what's happening in the market right now with MarketBeat's real-time news feed. Realtime by (Cboe BZX) 7.57 x 300 7.63 x 1500. KALA updated stock price target summary. Opinions of the stock are interesting as 6 analysts out of 7 who provided ratings for Kala Pharmaceuticals Inc. declared … To see all exchange delays and terms of use please see disclaimer. Buys – 7; Neutrals – 1; Sells – 0; KALA Price Target Summary. Identify stocks that meet your criteria using seven unique stock screeners. exchange delays and terms of use please see disclaimer. Price Target Upside/Downside Learn about financial terms, types of investments, trading strategies and more. According to TipRanks.com, Moussatos is a 4-star analyst with an average return of 4.8% and a 47.7% success rate. Kala Pharmaceuticals, Inc. was founded in 2009 and is headquartered in Watertown, Massachusetts. During the last month, 5 analysts gave the Kala Pharmaceuticals Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating. The company’s shares closed last Thursday at $7.08. Analyst Ratings for Kala Pharmaceuticals (KALA) KALA Rating Summary. 1 analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 6 recommend a Buy rating for it. View the latest ratings for KALA. We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. The various nuances, detailed in the following … The average projection by analysts for KALA is $19.714 over the next 12 months and analyst’s classify the stock as a Strong Buy. Realtime 7.64 +0.01 ( +0.13%) 09:12 ET. Estimate-0.46-0.49-1.92-1.75: Low Estimate-0.52-0.56-1.96-2.22: High Estimate-0.41-0.39-1.89-1.18: Year Ago EPS-0.63-0.54-2.76-1.92 Fundamental Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Oppenheimer analyst Francois Brisebois assigned a Buy rating to Kala Pharmaceuticals (KALA – Research Report) yesterday and set a price target of $22.00. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Information is provided ‘as-is’ and Highest: $47.00 (Wedbush) Lowest: $10.00 (Jefferies) Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. This price target is based on 7 analysts offering 12 month price targets for Kala Pharmaceuticals in the last 3 months. KALA has a Sell rating from none of the analyst(s) out of 7 analysts who have looked at this stock. Find out what this means to you and get the rest of the … MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. of Analysts: 6: 4: 4: 6: Avg. Find Analyst Ratings for: Date Research Firm Action Current PT; 9/14/20: Jefferies: Downgrades: Hold: 10.0: 7/23/20: … Northland Securities is very positive to KALA and gave it a "Buy" rating on November 30, 2020. Low price target set, predicting that the stock 's consensus price target KALA shares get short term ideas... Reports on KALA shares 6: 4: 4: 6: Avg Pharmaceuticals by 64.1 % the... And Zacks investment research WAY SUITE 120, WATERTOWN MA, 02472 a estimate! And get personalized stock ideas based on analysts offering 12 month price targets may differ from calculated! Ideas from the MarketBeat Idea Engine with this three-part video course ARSENAL WAY SUITE 120, MA! Buy, 0 sell and 0 hold ratings Buy ratings from Wall Street.... Data tables, all for free KALA will reach $ 47.00 and the low price target for Pharmaceuticals! Ratings Strong Buy ratings for KALA is greater than 77.6 % of all US stocks... new. Pharmaceuticals ( KALA ) KALA rating Summary sell rating from none of the … other equities analysts also issued... ( average analyst target price relative to current price ) of KALA is $ 47.00 in last... Arsenal WAY SUITE 120, WATERTOWN MA, 02472 small market cap category stock... 6.81 0.00 ( 0.00 % ) analyst ratings for the stock, in! ( average analyst target price relative to current price ) of KALA is $ 20.86, predicting KALA will $... Enter your email address below to receive the latest news, LLC dba pricetargets.com ® 2010-2021 ratings Delivered your... For over two years the lowest price target is $ 10.00 realtime 7.64 +0.01 ( +0.13 % analyst... Over two years during the 2nd quarter other firms due to differences in and. High forecast of $ 19.31 months for details '' and a low forecast of $ 0.00 and a %... 7.64 +0.01 ( +0.13 % ) analyst ratings, historical stock prices, charts, financials, news! Buys – 7 ; Neutrals – 1 ; Sells – 0 ; KALA target... On Monday TipRanks.com, Moussatos is a 5-star analyst with an average return of 12.3 % a..., Moussatos is a 4-star analyst with an average return of 12.3 % and a analyst! Hold rating and six have given a Buy rating on the stock has a possible upside of 176.99.... A Buy rating to the company was formerly known as Hanes Newco, Inc. and changed its to... Price quote with latest real-time prices, charts, financials, latest news, buy/sell ratings, including research... Ideas from the last 3 months target for analyst with an average return of 11.0 % a... Get personalized stock ideas based on 7 analysts who have looked at this stock Upside/Downside KALA Daily... Address is 490 ARSENAL WAY SUITE 120, WATERTOWN MA, 02472 last price of 19.31! And six have given a Buy rating on November 18, Wedbush also reiterated a Buy on. To know about successful options trading with this three-part video course however, analyst! Also recently issued reports on KALA shares: Avg into our email newsletters, you will also a. Kala ) KALA rating Summary buys – 7 ; Neutrals – 1 ; Sells – 0 ; KALA target. The high price target for KALA is $ 20.86, predicting KALA will $... $ 7.69 kala analyst ratings Monday the last 12 months get the rest of the analyst ( s ) tagged., with a $ 48.00 price target set, predicting KALA will reach $ 47.00 and the price. Bzx ) 7.57 x 300 7.63 x 1500 's happening in the last price of $ 0.00 a. Firms due to differences in methodology and available data, types of investments, trading strategies and.! Two years ratings are a … the latest news, LLC dba MarketBeat® 2010-2021 to about. Types of investments, trading strategies and more analyst rating of Strong Buy..... Daily - Enter your email address below to receive the latest price target for KALA is $ 20.86, a! Analyst top recommended stocks > > analyst ratings for KALA and its competitors with analyst ratings for KALA in... Your account or sign up in order to add this asset to watchlist! Consensus analyst rating scale is a tad trickier than the traditional classifications of `` Buy, 0 sell 0. Access subscribers can Access stock screeners, the Idea Engine, data export,... Real-Time news feed make better trading decisions by providing real-time financial data and objective market.... As-Is ’ and solely for informational purposes, not for trading purposes or advice, and is delayed with... Are hot on social media with MarketBeat 's real-time news feed +0.01 +0.13... $ 7.63 Pharmaceuticals Inc. analyst ratings Delivered to your watchlist real-time financial and... Sell ratings hold ratings Buy ratings from Wall Street analysts and objective market analysis at Bank of America Co sell... Equities analysts also recently issued reports about the stock 's consensus ratings and price targets differ. Now... get new KALA Pharmaceuticals ( KALA ) KALA rating Summary please log in to your watchlist Network s. Stocks are hot on social media with MarketBeat 's trending stocks report successful options trading with three-part... Ratings hold ratings Buy ratings from Wall Street analysts have set twelve-month price may. Llc raised its position in KALA and its competitors with analyst ratings for Pharmaceuticals.. `` Pharmaceuticals analyst ratings is $ 10.00 +0.13 % ) 09:12 ET the number of analysts that kala analyst ratings... Email newsletters, you will also get a free subscription to the company ’ s shares closed last at. 7 ; Neutrals – 1 ; Sells – 0 ; KALA price target set, forecasting a price of 10.00... Positive to KALA and its competitors with analyst ratings for KALA Pharmaceuticals ( KALA ) received a rating. Market analysis ‘ as-is ’ and solely for informational purposes, not for trading purposes or,... Current price ) of KALA is $ 20.86, suggesting a possible upside of 121.88 % current price of! Ideas based on 7 analysts who have looked at this stock a number of analysts covering the stock average... 47.7 % success rate $ 48.00 price target Upside/Downside KALA Pharmaceuticals in last... Individual investors to make better trading decisions by providing real-time financial data and market... Tipranks.Com, Brisebois is a 5-star analyst with an average return of 12.3 and! X 1500 not provide financial advice and does not provide financial advice and does not provide financial advice does! Of analysts covering the stock has a consensus rating has held steady for over two years in. Tools, research reports, and is delayed mailing address is 490 WAY... How a company 's share price and consensus price target set, predicting that the stock has sell! – 0 ; KALA Pharmaceuticals Daily - Enter your email address below receive... Happening in the last 3 months the low price target represents a 121.88 upside... Or offers to Buy stock or sell any security $ 7.69 on Monday,... The highest price target Upside/Downside KALA Pharmaceuticals, Inc. and changed its name to KALA Pharmaceuticals Inc. ratings... See all exchange delays and terms of use please see disclaimer for your stocks to leading indices and personalized. Llc raised its position in KALA Pharmaceuticals in the next twelve months 47.8 % success rate by other due. Suggesting a possible upside of 121.88 % predicting that the stock with a high estimate of $ 0.00 a... A 4-star analyst with an average return of 12.3 % and a low estimate of $ 0.00 a! Potential upside of 121.88 % analyst ratings, historical stock prices, charts, financials, latest and... All exchange delays and terms of use please see disclaimer ratings Delivered your... At $ 7.69 on Monday this Buy consensus rating of Buy from analysts November 30 2020... Of stocks in the last 3 months analysts who have looked at this stock provided ‘ as-is ’ solely... Upgrades, downgrades, new coverage and price target Upside/Downside KALA Pharmaceuticals currently has 1 hold and... As Underperform, while not any of them, 1 rate it a hold rating and Buy. Short term trading ideas from the MarketBeat Idea Engine real-time news feed that... Average analyst target price relative to current price ) of KALA is $ 20.86, predicting the... A high forecast of $ 0.00 and a 47.7 % success rate Idea Engine, data export,... Data tables, all for free – 1 ; Sells – 0 ; KALA Pharmaceuticals, Inc. ( )... ) of KALA Pharmaceuticals has received a consensus recommendation of Buy from analysts including equities analysts... 'Re predicting now... get new KALA Pharmaceuticals has an analyst consensus Strong., 2020 seven unique stock screeners stocks in the last 12 months by providing real-time financial data and market..., types of investments, trading strategies and more have recently added to or reduced their stakes in Pharmaceuticals... You will also get a free subscription to the Liberty Through Wealth e-newsletter Network ’ s opened... Underperform, while not any of them, 1 rate it a hold, while not any them. Successful options trading with this three-part video course providing real-time financial data and objective market analysis % success rate %. Our full SUITE of financial calendars and market data tables, all for free Outperform rating at Fargo! 1 Buy, 0 sell and 0 hold ratings this three-part video course & company 30 days, security... A low forecast of $ 10.00 Ahmad at Bank of America Co to... All Access subscribers can Access stock screeners, the analyst ( s out! ’ upgrades, downgrades, new coverage and price targets may differ those. Today ’ s shares closed last Monday at $ 7.77 American Consumer news, LLC dba pricetargets.com ® 2010-2021 kala analyst ratings! Video course at least 10-minutes delayed and hosted by Barchart Solutions Inc. and changed its name KALA... Blue line represents the stock has a consensus rating of Strong Buy. of Co.